This trial studies how well an interactive survivorship program works in improving healthcare resources in adolescent and young adult cancer survivors. By improving access to survivorship resources, health literacy, self-management skills, and support, an interactive survivorship program may help to improve adherence to adolescent and young adult healthcare guidelines and reduce cancer-related distress.
OUTLINE: Patients who have one or more elevated distress or low cardiometabolic or cancer health care adherence are randomized to Arm I or II. ARM I (INTERVENTION): Patients receive a personalized Survivorship Care Plan (SCP) and use the Interactive Survivorship Program to Improve Healthcare Resources (INSPIRE) mobile application. Patients may receive telehealth stepped care after 1 month. ARM II (CONTROL): Patients receive access to a study-specific control website that has annotated links to existing resources for adolescent and young adult (AYA) survivors. After 12 months, patients receive a personalized SCP and have access to the digital INSPIRE intervention program without telehealth calls.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Enrollment
549
Use INSPIRE mobile application
Access to a study-specific control website
Ancillary studies
Receive telehealth stepped care
Receive printed SCP materials
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
University of Pennsylvania/Abramson Cancer Center
Philadelphia, Pennsylvania, United States
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Change in distress score from baseline to 3 months
Will be assessed by Cancer and Treatment Distress (CTXD). The CTXD is a 22 item Likert type scale that contains 6 subscales: uncertainty, health burden, identity, medical demands, finances, and family strain. Scores on individual items range from 0 (none) to 3 (severe) distress related to an aspect of the cancer experience. Patients will meet the primary endpoint for lack of distress if they score \< 0.9 on the CTXD.
Time frame: From baseline to 3 months
Change in distress score from baseline to 12 months
Will be assessed by Cancer and Treatment Distress (CTXD). The CTXD is a 22 item Likert type scale that contains 6 subscales: uncertainty, health burden, identity, medical demands, finances, and family strain. Scores on individual items range from 0 (none) to 3 (severe) distress related to an aspect of the cancer experience. Patients will meet the primary endpoint for lack of distress if they score \< 0.9 on the CTXD.
Time frame: From baseline to 12 months
Proportion of healthcare adherence (HCA)-all
Patients will meet HCA endpoint if their percent of recommended screenings obtained within the past 12 months is \>= 80% for HCA-all.
Time frame: At 12 months
Proportion of HCA-cardiometabolic surveillance (CM)
Patients will meet each HCA endpoint if their percent of recommended screenings obtained within the past 12 months is \>= 80% for HCA-CM.
Time frame: At 12 months
Proportion of HCA-cancer surveillance (SM)
Patients will meet each HCA endpoint if their percent of recommended screenings obtained within the past 12 months is \>= 80% for HCA-SM.
Time frame: At 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.